Molecular Diversity, volume 25, issue 3, pages 1439-1460

Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery

Manish Kumar Tripathi 1
Abhigyan Nath 2
Tej P. Singh 1
A S Ethayathulla 1
Punit Kaur 1
2
 
Department of Biochemistry, Pt. Jawahar Lal Nehru Memorial Medical College, Raipur, India
Publication typeJournal Article
Publication date2021-06-23
scimago Q2
wos Q2
SJR0.585
CiteScore7.3
Impact factor3.9
ISSN13811991, 1573501X
Catalysis
Organic Chemistry
Drug Discovery
Inorganic Chemistry
Physical and Theoretical Chemistry
Molecular Biology
General Medicine
Information Systems
Abstract
The accumulation of massive data in the plethora of Cheminformatics databases has made the role of big data and artificial intelligence (AI) indispensable in drug design. This has necessitated the development of newer algorithms and architectures to mine these databases and fulfil the specific needs of various drug discovery processes such as virtual drug screening, de novo molecule design and discovery in this big data era. The development of deep learning neural networks and their variants with the corresponding increase in chemical data has resulted in a paradigm shift in information mining pertaining to the chemical space. The present review summarizes the role of big data and AI techniques currently being implemented to satisfy the ever-increasing research demands in drug discovery pipelines.
Found 
Found 

Top-30

Journals

1
2
3
1
2
3

Publishers

2
4
6
8
10
12
14
16
18
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST | RIS | BibTex | MLA
Found error?